Leerink Partnrs Issues Pessimistic Forecast for DGX Earnings
Quest Diagnostics Incorporated (NYSE:DGX – Free Report) – Leerink Partnrs reduced their Q2 2025 EPS estimates for shares of Quest Diagnostics in a note issued to investors on Tuesday, April 22nd. Leerink Partnrs analyst M. Cherny now expects that the medical research company will earn $2.56 per share for the quarter, down from their prior […]
Quest Diagnostics Incorporated (NYSE:DGX – Free Report) – Leerink Partnrs reduced their Q2 2025 EPS estimates for shares of Quest Diagnostics in a note issued to investors on Tuesday, April 22nd. Leerink Partnrs analyst M. Cherny now expects that the medical research company will earn $2.56 per share for the quarter, down from their prior […]
